Our analysis showed that the percentages of CD3+, CD4+ and CD8+ cells and the CD4+/CD8+ ratio were significantly increased when kanglaite was administered to HCC patients, indicating that the immune function of HCC patients was improved by kanglaite-mediated therapy. Here, CD4 is linked to hepatocellular carcinoma.